Progress Toward Global Eradication of Poliomyelitis, 2001
From the initiation of the global poliomyelitis eradication initiative in 1988 (1) through 2001, the number of countries where polio is endemic decreased from 125 to 10, and the number of reported polio cases decreased by >99% from an estimated 350,000 to <1,000. Wild type 2 poliovirus has not been detected worldwide since October 1999 (2) . The American and Western Pacific Regions of the World Health Organization (WHO) have been certified free of indigenous wild poliovirus (3, 4) . Current challenges to global polio eradication efforts include ongoing intense transmission in northern India, continued importations of wild poliovirus into polio-free areas, and the detection of circulating vaccine-derived poliovirus (cVDPV). This report summarizes global progress in polio eradication during 2001 and the current status of the initiative.
Implementation of Polio Eradication Strategies
In 2000, reported global vaccination coverage with 3 doses of oral poliovirus vaccine (OPV3) among children aged <12 months was 82%. Routine coverage varies across WHO regions. The African Region (AFR) reported the lowest OPV3 coverage (55% in 2000). In most countries or areas where polio remained endemic in 2001 (Figure 1 ), OPV3 coverage in 2000 was <50%.
All countries where polio is endemic and many countries where polio was recently endemic continued to conduct supplemental immunization activities (SIAs) during 2001. Approximately 575 million children in 94 countries received an estimated 2 billion doses of OPV during 300 rounds of National Immunization Days* (NIDs), sub-NIDs, or mop-up activities † . All countries used house-to-house vaccination in part or all of the SIA target areas as the primary means to reach the highest possible coverage of children aged <5 years.
The quality of acute flaccid paralysis (AFP) surveillance to indicate reliably the presence or absence of wild poliovirus has improved (Table 1 ). All regions have reached the WHOrequired annual nonpolio AFP detection rate of at least one per 100,000 persons aged <15 years (5) . Progress in AFP reporting during 2000-2001 was notable in AFR, especially in Nigeria and Ethiopia. Similar progress was made in improving the reliability of virological surveillance through collection of adequate stool specimens. In 2001, all WHO regions except AFR reached the certification requirement of collecting two adequate stool specimens from at least 80% of AFP cases.
The WHO-accredited global network of 147 collaborating laboratories supports eradication strategies. Improvements in the efficiency and logistics of stool specimen handling and transport between collaborating laboratories in many countries enabled the network to reduce reporting delay between onset of paralysis and receipt of final laboratory results.
Impact on Poliovirus Transmission
In 2001, 537 confirmed polio cases (as of March 10, 2002) were reported; 473 (88%) were laboratory-confirmed (Table 1) . In 2000, a total of 2,971 cases were reported, of which 719 (24%) were laboratory-confirmed. Because several AFP cases with onset of paralysis in 2001 are still pending final classification in all regions, the final number of confirmed cases for 2001 will be higher, but will probably remain below 1,000. During 2001, three polio-free countries detected importations of wild poliovirus: Bulgaria (7), Georgia, and Zambia. The origin of a wild virus detected in Mauritania in 2001 is uncertain, but the virus probably was imported from areas where polio is endemic. Virus importations were detected rapidly and triggered immediate and appropriate large-scale surveillance and vaccination responses that prevented spread of the imported virus.
Polio cases attributed to cVDPV type 1 were found in Haiti and the Dominican Republic during 2000-2001 and in the Philippines during 2001 (8). The virus in both episodes showed >2% genetic sequence difference from the parent Sabin virus (VP1 region of genome) and probably circulated for >2 years before being detected. Public health investigations suggest that low vaccination coverage is allowing cVDPVs to circulate and revert to wild-type characteristics. Mass vaccination campaigns with OPV appear to have interrupted cVDPV circulation in Hispaniola and are underway in the Philippines. The global polio laboratory network established additional procedures to screen for cVDPV. Regional reference laboratories now routinely conduct intratypic differentiation of all poliovirus isolates using both antigenic and molecular tests. Isolates with discrepant results are referred for genetic sequencing studies. Retrospective analysis of approximately 2000 Sabin isolates from AFP cases detected during 1998-2000 has not revealed additional cVDPV.
Preparations for Posteradication Activities
When transmission of wild poliovirus is interrupted globally, wild poliovirus will remain only in diagnostic, research, and vaccine production laboratories. The goal of laboratory containment is to minimize the risk for inadvertent reintroduction of wild poliovirus from a laboratory into human circulation. The Global Plan of Action for Laboratory Containment of Wild Poliovirus (9) requires countries to identify all laboratories storing wild poliovirus or potentially infectious materials to ensure proper handling or disposal under appropriate biosafety conditions. This process has begun in 110 countries.
Planning for postcertification vaccination policy has three main objectives: 1) to develop contingency plans for reintroduction of poliovirus after certification, 2) to prevent cVDPVs from circulating and causing outbreaks, and 3) to broaden the knowledge base to support building a global consensus Several challenges remain in reaching the global polio eradication goal. The combination of large, dense populations, poor sanitation, and low routine vaccination coverage in Nigeria, Pakistan, and northern India might result in sustained transmission in these countries into 2003. Delays in interrupting transmission also could occur in less populated, conflictaffected countries if conflicts intensify or if access to children in these countries cannot be sustained. In areas where routine OPV coverage is low, interrupting wild poliovirus transmission requires high-quality, supplementary vaccination. National polio eradication efforts require both continued vigilance by the health sector alone and increased political commitment and multisector mobilization at all administrative levels.
The global eradication program has identified and defined the key risks to eradication in each country and is implementing country-specific response plans. Following the example of India, Technical Advisory Groups (TAGs) of experts have been formed for most countries where polio remains endemic, with support from the global polio partnership. TAGs regularly review each country's program status and advise on optimal strategy implementation. AFP surveillance systems have improved dramatically through placement of additional polio field staff. Expert groups exist in almost every country to improve the accuracy of final AFP case classification. Genetic sequencing data are used more systematically to identify main poliovirus circulation areas. The ability of SIAs to reach every child has improved through house-to-house vaccination with emphasis on social mobilization and information activities.
Interagency coordination committees (ICCs) at regional, national, and subnational levels facilitate coordination of partner and multisector support for the polio program and focus on fundraising at the regional level. ICCs created for polio eradication are being used increasingly to coordinate partner input to strengthen vaccination systems including routine vaccination services and vaccine-preventable disease surveillance. During 2000-2001, polio funds were used to purchase approximately 700 vehicles for vaccination and surveillance. An estimated 30% of the cold chain in sub-Saharan Africa has been refurbished through polio eradication funds. Approximately 80% of the nearly 2,000 health-care staff recruited with polio funds are involved in planning and implementing routine vaccination services.
Access to all children, continued political commitment, and assurance of uninterrupted funding will be necessary to interrupt wild poliovirus transmission in countries where polio remains endemic. affect prompt sex partner notification and outbreak detection. In 1998, approximately 70% of chlamydia cases and 55% of gonorrhea cases were reported by private clinicians, including many affiliated with managed care organizations (MCOs) (2) . However, little is known about the completeness and timeliness of MCOs' STD case reporting practices. Three MCOs, three state health departments, and CDC evaluated reporting practices for chlamydial infection and gonorrhea by three large staff or group model* MCOs that used different reporting procedures. The findings indicate that state health departments were notified of 78%-98% of chlamydia cases and of 64%-80% of gonorrhea cases identified in these MCOs; the median interval between specimen collection and state health department receipt of a case report was <19 days.
To improve surveillance quality, other MCOs, including network model † MCOs, which provide most STD care in the United States, should evaluate surveillance quality and identify interventions for improvement.
This study evaluated the chlamydia and/or gonorrhea reporting practices used during 1995-1999 by clinicians affiliated with three large MCOs: chlamydia and gonorrhea reporting at HealthPartners, a staff model HMO in Minnesota, and at Harvard Vanguard Medical Associates (HVMA), a large group practice in Massachusetts that was a staff model component of Harvard Pilgrim Health Care during the study period; and chlamydia reporting at Kaiser Permanente Foundation Health Plan of Colorado (KPCO), a group model HMO. In Minnesota and Massachusetts, clinicians and laboratories are required to report both chlamydia infection and gonorrhea, while in Colorado, only laboratories are required to report chlamydia infection (3).
Reporting procedures varied by MCO. In the case of HealthPartners, laboratories used a Minnesota Department of Health (MDH) form to report a positive STD test result to a patient's clinician, who was then responsible for contacting the patient, prescribing appropriate medication, noting prescribed treatments on the form, and mailing it to MDH. In the case of HVMA, laboratories transmitted a positive test result electronically to a patient's clinician and a single HVMA infection control specialist, who verified the treatment prescribed (4), mailed the test and treatment report to the Massachusetts Department of Public Health (MDPH), and notified the clinician that the case had been reported to MDPH. In the case of KPCO, laboratories filled out a positive STD test result reporting card provided by the Colorado Department of Public Health and Environment (CDPHE), mailed the card to CDPHE, and delivered the test result to a patient's clinician.
For this evaluation, each MCO created a database of positive tests for chlamydia infection and/or gonorrhea among MCO members. This database included all laboratoryconfirmed cases of chlamydia infection and gonorrhea at HealthPartners during January 1997-December 1998 and at HVMA during January 1995-December 1997, and all laboratory-confirmed cases of chlamydia infection at KPCO during January-June 1999. These data were transferred confidentially to the respective state STD programs for case matching to determine whether laboratory-confirmed cases had been reported to state health departments.
Laboratory-confirmed cases of chlamydia infection and gonorrhea were matched to state STD registry databases in Minnesota and Massachusetts by patient name, date of birth, sex, specimen collection date, and disease pathogen, and in Colorado by patient name, date of birth, and date of positive test. Matched cases were defined as those for which all variables matched exactly. A case initially unmatched by these variables was reclassified as matched if the patient's address, phone number, or medical record number matched, and the initial mismatch was attributed to typographic error, transposition of first and last names, or a recent last name change. Completeness of reporting was defined as the proportion of cases in the MCO database classified as matched in the state registry database. Timeliness of reporting was defined for HealthPartners and HVMA as the time between specimen collection and entry of case report into the state registry database. Because CDPHE staffing shortages precluded data entry more than once every 6 months, timeliness was defined for KPCO as the time between the date a positive test was identified in the laboratory and the date of receipt by health department staff.
At HealthPartners (Minnesota), 654 (78%) of 841 chlamydia cases and 204 (80%) of 256 gonorrhea cases were matched. Case reports were entered into MDH's registry within a median of 19 days (mean: 33 days, range: 4-380 days) and a median of 17 days (mean: 30 days, range: 6-159 days) after chlamydia and gonorrhea specimen collection, respectively. At HVMA (Massachusetts), 800 (78%) of 1,032 chlamydia cases and 225 (64%) of 354 gonorrhea cases were matched. Case reports were entered into MDPH's registry within a median of 17 days (mean: 38 days, range: 1-268 days) and a median of 14 days (mean: 14 days, range: 1-189 days) after chlamydia and gonorrhea specimen collection, respectively. At KPCO (Colorado), 226 (98%) of 231 chlamydia cases were matched. Case reports were received by CDPHE within * Physicians in a staff model HMO practice as salaried employees. Physicians in a group model HMO are members of a group that receives a monthly fee for every enrolled patient. † Physicians in a network model HMO might be members of one group or two or more groups that contract to provide services for a monthly fee.
Editorial Note: Several system-level factors might have contributed to the fairly high completeness of STD reporting at these MCOs: 1) a single, centralized reporting system handling reports from all MCO-affiliated laboratories; 2) MCOs' established relations with state STD programs; and 3) MCO Web site and newsletter communication to clinicians about trends in STD morbidity among members of two MCOs. The first two features are typical of staff or group model MCOs but rare in other MCO models (e.g., network model HMOs) that dominate the MCO market (5) .
A higher proportion of chlamydia cases was reported by these three large staff or group model MCOs than by private clinicians in North Carolina (55%), the only state for which an evaluation of STD reporting in private health care settings has been published (6) . However, the lower completeness of reporting found in that study might reflect chlamydia infection having become a reportable disease in North Carolina 5 years earlier. The average completeness of reporting at HealthPartners and HVMA for gonorrhea was similar to that in the North Carolina study (72%).
Although completeness of reporting was fairly high in these three MCOs, the median interval between test specimen collection or processing and receipt or entry of the report by the state health department ranged from 6-19 days. Delayed reporting might slow initiation of services for sex partners and detection of outbreaks, which might reduce the effectiveness of STD control measures (7). Such delays might be associated with the time taken to transfer specimens to laboratories, process specimens in the laboratories, verify treatment, and transmit reports to state health department using regular mail. Delays also might be associated with the time elapsed from the date of receipt to the date of manual entering or scanning of cases at health departments. In addition, manual entering and scanning of data at state health departments might result in mismatches in case information between MCO databases and state STD registry databases. To improve the completeness and timeliness of STD reporting, MCOs might consider collaborating with state health departments to use confidential electronic data transfer systems (8) to transfer STD test results to state health departments. MCOs might find implementing an electronic data transfer system for laboratory-based reporting from a small number of laboratories easier than for provider-based reporting from hundreds of affiliated providers. CDC, with the collaboration of state and local health departments, is implementing a National Electronic Disease Surveillance System (NEDSS) to better manage and enhance current surveillance systems and enable the public health community to respond more quickly to public health threats (9). When implemented, NEDSS will help state health departments receive electronic data.
The findings in this report are subject to at least three limitations. First, the completeness of reporting might have been underestimated slightly because some reports-those with suspected typographic errors in name, date, or disease type and those that were lost during mailing-could not be fully verified. Second, reporting of information that might improve matching (e.g., medical record number, address, or phone number) is not mandated by the three states evaluated and is commonly omitted from reports. Finally, the STD reporting practices in these three staff and group model MCOs might not be representative of other MCOs, especially network models that lack central laboratories, central electronic data transfer capacity, dedicated reporting staff, and regular communication to clinicians about STD rates of the MCO members. However, some features common to staff or group model MCOs that might facilitate STD reporting are readily introduced by other MCO models (e.g., Web site communication to clinicians about STD rates of MCO members).
MCOs that have centralized facilities, staffs, data systems, policies, and the capacity to reach large numbers of patients and clinicians are well positioned to make system-level interventions that will promote more complete and timely STD reporting. 
Oral Health Survey of Third Grade Students -New Hampshire, 2001
Dental caries is one of the most common chronic disease of childhood (1) . Despite improvements in oral health in the United States, by late adolescence approximately 80% of children have a history of caries (1). To establish a baseline for monitoring oral disease trends in New Hampshire, the New Hampshire Department of Health and Human Services in cooperation with the New Hampshire Department of Education conducted a statewide assessment of the oral health status of third grade students attending public schools during the 2000-2001 academic year. This report summarizes the findings of the survey, which indicate that approximately one half of third grade students in New Hampshire have experienced dental decay. Increasing access to fluoridated water and dental sealants is needed to prevent childhood caries.
The survey was based on methodology outlined in the Basic Screening Surveys, a set of standardized, cross-sectional oral health surveys that can be used to collect data for monitoring the national health objectives for 2010 (2) . Schools were selected with probability proportional to third grade enrollment size. One third grade class in each school was then selected randomly and all students in that class were eligible to participate. Of 273 public schools with 16,685 third grade students, 27 (9.9%) schools were selected. Only students with parental consent were eligible to participate. Each school decided whether consent was active or passive. For schools allowing active consent, parents wanting their child to participate in the screening were required to return a signed consent form. For schools requiring passive consent, all children were screened except those who returned a parental consent form requesting they not participate. Brief noninvasive dental screenings were conducted by five dental hygienists during February-April 2001; one hygienist conducted 85.9% of the screenings. Students (n=70) in five participating schools had been screened in school-based dental programs within 2 months of the start of the survey; data for these students were abstracted from existing records. Data were tabulated according to the percentage of children with dental caries experience, untreated decay, presence of sealants on permanent molars, and urgency of care. The need for early dental care was defined as having untreated dental caries without accompanying signs or symptoms, the presence of spontaneous bleeding of the gum, or suspicious white or red soft tissue areas. Urgent need for dental care included signs or symptoms consistent with pain, infection, swelling, or soft tissue ulceration of >2 weeks duration (2) .
Of the 27 schools selected, 26 (96.3%) participated. The participating schools were located in 22 towns representing nine of the 10 counties in the state. Of the 507 eligible students, 410 (80.8%) were screened. The overall response rate was 77.9%. Almost all (98.8%) children screened were aged 8 or 9 years; 50.2% were female. Among children screened, 52.0% (95% confidence interval [CI]=45.5%-58.4%) had a history of dental caries, 21.7% (95% CI=14.3%-29.1%) had untreated decay, and 45.9% (95% CI=37.7%-54.0%) had a dental sealant on at least one permanent molar. Among children screened, 69.8% (95% CI=62.7%-76.8%) had no obvious dental problems, 25.1% (95% CI=19.1%-31.2%) required early care, and 5.1% (95% CI=3.0%-7.3%) required urgent care. Editorial Note: This survey provided New Hampshire health officials with the first statewide data to assess the oral health status of children. The survey was conducted quickly (i.e., 20 days) and inexpensively (i.e., screening budget=$5,000) by using the Basic Screening Surveys (2), limiting the sample size, and restricting the amount of data collected.
CDC, in collaboration with the Association of State and Territorial Dental Directors, developed the National Oral Health Surveillance System (NOHSS) to help public health programs monitor the burden of oral disease, the use of the oral health care delivery system, and the status of community water fluoridation on both a state and national level (3). NOHSS includes eight oral health surveillance indicators: four for adults (i.e., dental visits, teeth cleaning, tooth loss, and oral cancer), three for children (i.e., caries experience, untreated caries, and dental sealants) and one involving communities (i.e., fluoridation status). This survey provided New Hampshire data for the three indicators in the NOHSS that were specific to children.
The findings of this survey were consistent with a similar survey conducted in Maine in 1999. In the Maine survey involving 1,297 third grade children, 20.4% had untreated decay, 44.7% had a history of decay, and 47.6% had sealants (4). The national health objectives for 2010 regarding oral health include decreasing the proportion of children aged 6-8 years with untreated decay to 21% (objective 21-2), decreasing the proportion of children aged 6-8 years with a history of caries to 42% (objective 21-1), and increasing the proportion of children aged 8 years with sealants to 50% (objective 21-8) (5) .
The findings in this report are subject to at least three limitations. First, the survey was restricted to third grade students in public schools. In New Hampshire, 8% of third grade students attend private schools. Second, assessing the presence of interproximal caries, tooth-colored restorations, and clear sealants can be difficult in a noninvasive screening examination; therefore, the results might underestimate the prevalence of both untreated and treated decay and sealants (6) . Third, the type of consent process selected by the schools might have resulted in selection bias. Of 298 eligible students, 273 (91.6%) participated in schools requiring passive consent compared with 137 (65.6%) of 209 eligible students in schools requiring active consent.
New Hampshire is approaching the 2010 national targets for two of three oral health objectives; however, only 43% of the state's residents on public water supply receive fluoridated water. Further progress in attaining the oral health objectives will require efforts to promote water fluoridation, expand sealant usage, and improve access to dental care for those without such services.
Erratum: Vol. 51, No. 11
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